MYOS RENS TECHNOLOGY INC.·4

Nov 18, 7:23 PM ET

Rawlins Dave 4

4 · MYOS RENS TECHNOLOGY INC. · Filed Nov 18, 2020

Insider Transaction Report

Form 4
Period: 2020-11-17
Rawlins Dave
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-11-17+224,630224,630 total
    Exercise: $1.71From: 2020-11-17Exp: 2029-12-12Common Stock (224,630 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-11-17+74,320298,950 total
    Exercise: $1.71From: 2020-11-17Exp: 2030-04-24Common Stock (74,320 underlying)
Footnotes (3)
  • [F1]Price in Canadian dollars.
  • [F2]1/48 of the shares vest monthly beginning on August 12, 2019, subject to the Reporting Person continuing as a service provider through each such date.
  • [F3]1/48 of the shares vest monthly beginning on February 28, 2020, subject to the Reporting Person continuing as a service provider through each such date.

Documents

1 file
  • 4
    wf-form4_160574540126647.xmlPrimary

    FORM 4